Bain Capital Life Sciences Investors, LLC

Holdings History for NewAmsterdam Pharma Co N.V. - Ordinary Shares, nominal value EUR0.12 per share (NAMS)

Symbol: NAMS on Nasdaq
Investment type: Equity / Ordinary Shares, nominal value EUR0.12 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	20%	-9.2%	$256,314,335	7,306,566	-3,412,544	-32%	$35.08	Q4 2025
30 Sep 2025	20%	0%	$304,851,488	10,719,110	0		$28.44	Q3 2025
30 Jun 2025	24%	0%	$194,123,082	10,719,110	0		$18.11	Q2 2025
31 Mar 2025	32%	0%	$219,420,182	10,719,110	0		$20.47	Q1 2025
31 Dec 2024	32%	+0.74%	$275,481,127	10,719,110	+245,197	+2.3%	$25.70	Q4 2024
30 Sep 2024	18%	0%	$173,866,956	10,473,913	0		$16.60	Q3 2024
30 Jun 2024	22%	0%	$201,203,869	10,473,913	0		$19.21	Q2 2024
31 Mar 2024	20%	0%	$247,708,042	10,473,913	0		$23.65	Q1 2024
31 Dec 2023	11%	0%	$116,993,608	10,473,913	0		$11.17	Q4 2023
30 Sep 2023	11%	0%	$96,883,695	10,473,913	0		$9.25	Q3 2023
30 Jun 2023	13%	+2.7%	$124,534,826	10,473,913	+2,173,913	+26%	$11.89	Q2 2023
31 Mar 2023	14%	0%	$110,058,000	8,300,000	0		$13.26	Q1 2023
31 Dec 2022	10%	+10%	$90,470,000	8,300,000	+8,300,000	NEW	$10.90	Q4 2022

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.